Dose-finding, Safety, Efficacy Trial of Topical Resiquimod in Patients With Multiple Actinic Keratosis Lesions
Clinical trial NCT01583816 · COMPLETED
Trial details
- NCT number
- NCT01583816
- Sponsor
- Spirig Pharma Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-01
- Primary completion
- 2013-11-01
- Enrollment
- 218
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.